Theriva Biologics (FRA:SFY) Long-Term Capital Lease Obligation : €1.20 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Theriva Biologics Long-Term Capital Lease Obligation?

Theriva Biologics's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.20 Mil.

Theriva Biologics's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (€1.45 Mil) to Dec. 2023 (€1.32 Mil) and declined from Dec. 2023 (€1.32 Mil) to Mar. 2024 (€1.20 Mil).

Theriva Biologics's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (€1.24 Mil) to Dec. 2022 (€1.12 Mil) but then increased from Dec. 2022 (€1.12 Mil) to Dec. 2023 (€1.32 Mil).

Theriva Biologics Long-Term Capital Lease Obligation Historical Data

The historical data trend for Theriva Biologics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theriva Biologics Long-Term Capital Lease Obligation Chart

Theriva Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.43

0.15

1.24

1.12

1.32

Theriva Biologics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.68	1.55	1.45	1.32	1.20

Theriva Biologics (FRA:SFY) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Theriva Biologics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Theriva Biologics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Theriva Biologics (FRA:SFY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

TOVX:USA

Address

9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850

Website

https://www.therivabio.com

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Theriva Biologics (FRA:SFY) Headlines

From GuruFocus

SOFI WEALTH, LLC Goes on Buying Spree in 2nd Quarter

By GuruFocus Research GuruFocus Editor • 07-25-2022

SoFi Releases SoFi Gig Economy ETF (GIGE) and SoFi 50 ETF (SFYF)

By PRNewswire PRNewswire • 05-08-2019